News

Researchers develop a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.

Researchers developed a universal flu vaccine, which analyzed thousands of virus strains to identify conserved proteins. In animal trials, the vaccine elicited a strong immune response and provided protection against multiple flu strains.

Researchers discovered that targeting the ERBB2 gene in mice with PTEN mutations significantly slowed endometrial cancer growth. This finding offers hope for alternative treatments beyond hysterectomy and aggressive therapies.

Scientists at St. Jude Children’s Research Hospital and Washington University School of Medicine found that T follicular helper cells determine the effectiveness of vaccine-induced immunity against flu.

A team led by CUNY Graduate Center biologists has produced a genetic analysis of Lyme disease bacteria that may pave the way for improved diagnosis, treatment, and prevention of the tick-borne ailment.

A new technique developed by McGill researchers for mechanically manipulating stem cells could lead to new stem cell treatments.

Houston Methodist researchers have discovered a more accurate and timely way to deliver life-saving drug therapies to the brain, laying the groundwork for more effective treatment of brain tumors and other neurological diseases.

Patients in England with severe beta-thalassaemia will be amongst the first in Europe to benefit from one-time gene therapy exagamglogene autotemcel (“exa-cel”, also called Casgevy and made by Vertex).

This may come as a surprise, but the BCG vaccine against tuberculosis is the oldest immunotherapy against cancer. Now, a team from the Champalimaud Foundation, in Lisbon, has found the first steps of its action to destroy cancer cells.

A new study looks into how deficiency of the enzyme NMNAT2 renders the nerve cells of the eye vulnerable to neurodegeneration and could be a key in the search for a treatment.